IP Verse

Combination Immunotherapy For The Treatment Of Cancer - EP2482849

PATENT ANALYSIS

Patent Details

Grant Date: Jun 6, 2018
Company: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Oppositions

More patents of Board Of Regents, The University Of Texas System

Want to monitor this patent?

Feel free to send us a message here and we will get back to you